$24.39
1.235.31%
At Close: -
$24.39
00.00%
After Hours: 7:58 PM EDT
15 minutes delayed
Comments
Loading...
Summit Therapeutics (NASDAQ:SMMT) Stock, Earnings Estimates, EPS, And Revenue
Summit Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 5
EPS Estimate
$-0.070
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Summit Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Summit Therapeutics (SMMT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-06 | $-0.05 | $-0.06 | 16.7 % |
| Sep 2021 | 2021-11-15 | $-0.20 | $-0.28 | 28.6 % |
| Sep 2019 | 2019-12-17 | $-0.05 | $-0.40 | 87.5 % |
Summit Therapeutics (SMMT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2021 | 2021-08-11 | $57.00K | $4.45M | -98.7 % |
| Sep 2019 | 2019-12-17 | $152.52K | $4.67M | -96.7 % |
FAQ
When is Summit Therapeutics (NASDAQ:SMMT) reporting earnings?
Summit Therapeutics (SMMT) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
What were the latest earnings per share (EPS) for Summit Therapeutics (NASDAQ:SMMT)?
The Actual EPS was $-0.05, which beat the estimate of $-0.06.
What were Summit Therapeutics’s (NASDAQ:SMMT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.